Início › Linfoma folicular › Washington › Seattle
Ensaios clínicos de Linfoma folicular em Seattle, WA
15 estudos para Linfoma folicular estão buscando participantes em locais em Seattle e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
RecrutandoFase 1/2
- Research Site, Seattle
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
RecrutandoFase 1/2
- Fred Hutchinson Cancer Research Center, Seattle
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
RecrutandoFase 1
- University of Washington - Fred Hutchinson Cancer Center (Seattle Cancer Care Alliance), Seattle
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
RecrutandoFase 1
- Swedish Cancer Institute (SCI), Seattle
A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
RecrutandoFase 1/2
- Fred Hutchinson Cancer Research Center, Seattle
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
RecrutandoFase 3
- Fred Hutch Cancer Center, Seattle
Low Dose Mosunetuzumab for the Treatment of Patients With Indolent B-Cell Lymphoma
RecrutandoFase 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma
RecrutandoFase 1
- Fred Hutchinson Cancer Center, Seattle
Pirtobrutinib and Mosunetuzumab for the Treatment of Relapsed/Refractory Grades 1-3A Follicular Lymphoma, PROMOTE-FL Trial
RecrutandoFase 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
RecrutandoFase 2Voluntários saudáveis bem-vindos
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Study of SGR-1505 in Mature B-Cell Neoplasms
RecrutandoFase 1
- Fred Hutchinson Cancer Center, Seattle
A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma
RecrutandoFase 1/2
- University of Washington-Seattle Cancer Care Alliance, Seattle
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecrutandoEstudo observacional
- Massive Bio SYNERGY-AI site, Seattle
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
RecrutandoFase 1
- Swedish Cancer Institute, Seattle
Study of the Clinical Impact of Surgical Correction of Tricuspid Insufficiency in Implantable LVAD Patients
Recrutando
- University of Washington Medical Center, Seattle
Ensaios de Linfoma folicular em outras cidades
- New York City, NY24 estudos
- Milwaukee, WI19 estudos
- Nashville, TN18 estudos
- Houston, TX18 estudos
- Boston, MA17 estudos
- Baldwin Park, CA16 estudos
- Durham, NC15 estudos
- Columbus, OH13 estudos
- Salt Lake City, UT13 estudos
- San Antonio, TX12 estudos
- Chicago, IL12 estudos
- Philadelphia, PA12 estudos
Outros estudos em Seattle
- Câncer de Pulmão de Não Pequenas Células53 estudos
- Câncer (todos os tipos)49 estudos
- Câncer de Próstata42 estudos
- Leucemia Mieloide Aguda40 estudos
- Câncer de Mama39 estudos
- Câncer Metastático39 estudos
- Câncer Colorretal34 estudos
- Câncer de Pulmão33 estudos
- Câncer de Ovário30 estudos
- Mieloma Múltiplo22 estudos
- Síndromes Mielodisplásicas21 estudos
- Leucemia Linfoblástica Aguda21 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.